<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Inati</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Taher</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ghorra</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Koussa</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Taha</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Aoun</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2005</year>). 
  <article-title>Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepathitis C virus infection</article-title>. 
  <source>Br. J. Haematol</source>. 
  <volume>130</volume>, 
  <fpage>644</fpage>â€“
  <lpage>646</lpage>. 
  <pub-id pub-id-type="doi">10.1111/j.1365-2141.2005.05645.x</pub-id>
  <?supplied-pmid 16098081?>
  <pub-id pub-id-type="pmid">16098081</pub-id>
 </mixed-citation>
</ref>
